scorecardresearch
Add as a preferred source on Google
Monday, December 15, 2025
TopicCovaxin

Topic: Covaxin

Zee News on vaccine approval, Times Now on ‘green shoots’ in Indian economy

A quick take on what prime time TV news talked about.

Submit Covaxin safety reports every 15 days, include mild side-effects — govt to Bharat Biotech

Drug regulator DCGI’s approval to Bharat Biotech’s Covaxin for emergency use is subject to certain conditions detailed in the ‘permission form’.

Congress questions why Bharat Biotech’s Covaxin was cleared without completing phase-3 trials

Congress’ Anand Sharma, head of parliamentary panel, says health ministry needs to explain sidestepping protocol because Covaxin will be given to frontline workers.

Covaxin approved as it’s more likely to act against mutant Covid strain, says ICMR chief

In an interview, ICMR chief Balram Bhargava addressed questions that have been raised about the approval granted to Covaxin in the absence of efficacy data.

Strict follow-up, informed consent from recipients — conditions set for cleared Covid vaccines

India has given conditional emergency-use licence to two Covid vaccines — the Oxford-AstraZeneca candidate Covishield, and Bharat Biotech’s Covaxin.

Bharat Biotech’s Covaxin given conditional nod based on incomplete Phase 3 trial results data

Covaxin has been recommended for restricted emergency use authorisation by a subject expert committee appointed by the Central Drugs Standard Control Organisation.

Everything you need to know about Covaxin, India’s controversial Covid vaccine candidate

Bharat Biotech's Covaxin has been recommended for restricted emergency use authorisation by an expert committee appointed by the Central Drugs Standard Control Organisation.

Covid protection with placebo too? Bharat Biotech’s pitch for volunteers raises concerns

Bharat Biotech has asked Covaxin trial sites to offer Covid protection as an incentive to draw volunteers. Experts say it is unethical.

Covaxin Phase 2 trials find Covid vaccine safe, no serious adverse events reported

Researchers, however, said evaluation of safety outcomes required extensive phase 3 clinical trials of the Covid vaccine developed through partnership between ICMR & Bharat Biotech.

Covaxin Phase I trial results show vaccine is safe, generates immune response

In a preprint paper, researchers from Bharat Biotech, ICMR, AIIMS have reported the results of the trial on 375 participants. 

On Camera

Why district judges almost never make it to India’s Supreme Court

Indian judiciary has a corrosive imbalance between the bar and the bench. Those who supervise the district judiciary do so without the lived experience that is essential for meaningful reform.

Rupee’s turmoil has echoes of 2013

With the US-India trade deal yet to get done, rupee depreciation may be helping to mitigate India’s loss of competitiveness. The other problem is extreme despondence among overseas equity investors.

US clears $686-mn package to breathe fresh life into Pakistani F-16s

Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).

India’s top airline just handed sarkar the keys. That’s IndiGo’s real ‘crime’

Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.